Trial Condition(s):

Sunscreening Agents

18612 - Sun Protection Factor Assay

Bayer Identifier:

18612

ClinicalTrials.gov Identifier:

NCT02760576

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

To evaluate the Sun Protection Factor efficacy on human skin.

Inclusion Criteria
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing; Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
                - Male and female.
                - Aged between 18-70 years old.
                - Good health as determined from the HRL SHF (Subject History Form).
                - Signed and dated Informed Consent Form.
                - Signed and dated HIPAA Form (Health Insurance Portability and Accountability Act).
                - An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose).
Exclusion Criteria
- Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
 - Pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
 - Pre-existing other medical conditions (e.g. adult asthma, diabetes).
 - Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
 - Treatment with antibiotics within two weeks prior to initiation of the test.
 - Chronic medication which could affect the results of the study.
 - Known pregnant or nursing women.

Trial Summary

Enrollment Goal
10
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
BAY987521
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Locations
Locations

Investigative Site

Union, United States, 07083

Trial Design